BioAtla share price logo

BioAtla

OTC: BCAB

$1.34

-0.18

(-11.84%)

Live

as on

BioAtla Stock Performance

as on September 26, 2026 at 4:03 am IST

  • Day's Low

    $1.17
    $1.34
    downward going graph

    12.69%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.07
    $71.50
    downward going graph

    20.15%

    Downside

    5235.82%

    Upside

    downward going graph

BioAtla share price movements today

Previous Close
$1.52
Open
$1.31
Volume
175.6K
Market Cap
$2.6M
Day's Low - High
$1.17 - $1.34
52 Week Low - High
$1.07 - $71.50

BioAtla Historical Returns

1 Month Return
-53.37 %
3 Month Return
-57.18 %
1 Year Return
-95.17 %
3 Year Return
-98.23 %
5 Year Return
-99.9 %

BioAtla Stock Fundamentals & Key Indicators

Check BioAtla market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.6M

EPS (TTM)

-25.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.07

Industry PE ratio

-2.69

PEG Ratio

-0.0009125181283438816

EBITDA

-29.2M

Revenue (TTM)

8.5M

Profit Margin

-4.15%

Return On Equity TTM

89.25%

BioAtla Stock Valuation

Track how BioAtla P/E has moved over time to understand its valuation trends.

BioAtla in the last 5 years

  • Overview

  • Trends

Lowest (-7.11x)

December 31, 2021

Industry (-2.69x)

December 31, 2025

Today (-0.56x)

December 31, 2025

Highest (-0.41x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.56x

BioAtla vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioAtla with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$2.6M-99.9%-0.07-4.15%0.00%
StrongBuy$40.9B550.8%-21.530.00%0.00%
StrongBuy$130.9B184.51%29.8186.04%0.00%
Neutral$72.7B-54.71%-22.82-12.57%0.00%
Buy$82.8B24.59%19.1584.86%0.46%

Stock Returns calculator for BioAtla Stock including INR - Dollar returns

The BioAtla stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

BioAtla investment value today

Current value as on today

₹4,592

Returns

-₹95,408

(-95.41%)

Returns from BioAtla Stock

-₹95,745 (-95.75%)

Dollar Impact

₹338 (+0.34%)

Analyst Recommendation on BioAtla Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for BioAtla. Average target price of $10

BioAtla Share Price Target

Get share price movements and forecasts by analysts on BioAtla.

What analysts predicted

86.6%UPSIDE

Target Price

$10

Current Price

$1.34

Analyzed by

11 Analysts

Target

$10.00

BioAtla target price $10, a slight upside of 86.6% compared to current price of $1.34. According to 11 analysts rating.

Indian Investors' Interest in BioAtla Stock

Search interest for BioAtla Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:52% versus previous 30 day period

BioAtla Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
11
-
-
-
-
2
-
6
Gross Profit
0
0
10
-11
0
0
-9
2
0
6
Operating Income
-24
-21
-11
-16
-17
-18
-13
-9
-8
0
EBITDA
-22
-20
-10
-14
-15
-18
-15
-7
-6
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-23
-21
-10
-14
-15
-18
-15
-9
-6
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-23
-21
-10
-14
-15
-18
-15
-9
-6
0
Net Profit Margin
0.00%
0.00%
97.93%
0.00%
0.00%
0.00%
0.00%
140.30%
0.00%
100.00%

BioAtla Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
5
0
0
-
-
11
2
Gross Profit
-15
-20
-19
-58
-1
-1
10
-41
Operating Income
-28
-28
-30
-96
-108
-129
-73
-59
EBITDA
-27
-27
-33
-94
-105
-122
-68
-59
Interest Expense
0
1
1
0
-
-
-
-
Depreciation
0
0
1
1
1
1
0
0
Income Before Tax
-28
-29
-35
-95
-106
-123
-69
-59
Income Tax Expense
0
-
-
-
-
-
-
-
Net Income
-28
-29
-35
-95
-105
-123
-69
-59
Net Profit Margin
-147.53%
-398.44%
-4546.39%
100.00%
0.00%
0.00%
91.59%
-2053.65%

BioAtla Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-23
-21
-10
-14
-15
-18
-15
-9
-6
0
Operating Cash Flow
-30
-19
-5
-16
-16
-14
-9
-7
-5
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
9
0
0
0
6
0
0
Change in Cash
-30
-18
-5
-7
-16
-14
-9
-1
-5
0

BioAtla Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-28
-29
-35
-95
-106
-123
-69
-59
Operating Cash Flow
-35
-9
-36
-62
-90
-104
-71
-48
Investing Cash Flow
0
-1
0
0
0
0
-
-
Financing Cash Flow
5
3
271
69
61
0
9
6
Change in Cash
-31
-7
234
6
-29
-104
-62
-41

Mutual Funds that own BioAtla Stock

Check out the Mutual Funds with significant holdings in BioAtla.

Funds
Holdings
Shares Held
TIAA-CREF Funds
9.875157%
164530
Northern Funds
0.974371%
16234
HC Capital Trust
0.671688%
11191
Victory Portfolios III
0.244943%
4081
TIAA-CREF Funds
9.875157%
164530

Global Institutional Holdings in BioAtla

Funds
Holdings
TIAA-CREF Funds
9.88%
Northern Funds
0.97%
HC Capital Trust
0.67%
Vanguard
0.55%
Xtrackers
0.45%

Insights on BioAtla

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 22.0% return, outperforming this stock by 120.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 565.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BCAB stock has moved down by -47.1%

About BioAtla

BioAtla Inc. is a biopharmaceutical firm currently in the clinical development phase, focused on creating highly specific and selective antibody-derived treatments designed to combat solid tumor cancers. The company's primary experimental therapeutic, BA3011, is a conditionally active biologic antibody-drug conjugate (CAB ADC) being investigated for its potential against soft tissue and bone sarcoma, non-small cell lung cancer (NSCLC), and ovarian cancer. Additionally, BioAtla is advancing BA3021, another CAB ADC, for a variety of solid malignancies such as NSCLC, melanoma, and ovarian cancer. A third candidate, BA3071, is a conditionally active anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) antibody aimed at a broad spectrum of cancers, including renal cell carcinoma, non-small cell and small cell lung cancers, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. Established in 2007, BioAtla Inc. operates out of San Diego, California.
OrganisationBioAtla
Headquarters11085 Torreyana Road, San Diego, CA, 92121, US
IndustryBiotechnology
CEOJay Short
E-voting on sharesClick here to vote

Key Management of BioAtla

Name

Title

Dr. Eric L. Sievers M.D.

Chief Medical Officer

Ms. Susie Melody

Senior Vice President of Human Resources

Dr. Cathy Chang Ph.D.

Senior Vice President of Research & Development

Dr. Gerhard Frey Ph.D.

Senior Vice President of Technology Development

Ms. Monica Sullivan

Senior Vice President of Intellectual Property & Contracts

Ms. Sheri Lydick

Chief Commercial Officer

Lisa M. Pelton

Accounting Manager

Dr. Jay M. Short Ph.D.

Co-Founder, CEO & Chairman

FAQs

What is BioAtla share price today?

BioAtla share price today is $1.34 as on . BioAtla share today touched a day high of $1.34 and a low of $1.17.

What is the 52 week high and 52 week low for BioAtla share?

BioAtla share touched a 52 week high of $71.50 on and a 52 week low of $1.07 on . BioAtla stock price today i.e. is trending at $1.34,which is 98.13% down from its 52 week high and 25.23% up from its 52 week low.

What is BioAtla's market capitalisation today?

BioAtla market capitalisation is $0.00T as on .

How to invest in BioAtla Stock (BCAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioAtla on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioAtla Shares that will get you 1.1194 shares as per BioAtla share price of $1.34 per share as on September 25, 2026 at 10:33 pm IST.

What is the minimum amount required to buy BioAtla Stock (BCAB) from India?

Indian investors can start investing in BioAtla (BCAB) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in BioAtla stock (as per the Rupee-Dollar exchange rate as on ). Based on BioAtla share’s latest price of $1.34 as on September 25, 2026 at 10:33 pm IST, you will get 7.4627 shares of BioAtla. Learn more about fractional shares .

What are the returns that BioAtla has given to Indian investors in the last 5 years?

BioAtla stock has given -99.9% share price returns and 29.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?